Drug Trial Radar · NCT03362190
ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
Last checked: Nov 20, 2026Latest source record: Jun 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Oct 11, 2017
Primary completion
Oct 18, 2018
Study completion Oct 18, 2018
Sponsor
- Lead sponsor
- Ophthotech CorporationIndustry
- Sponsor type
- Industry
- First posted
- Dec 5, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the safety of intravitreal Zimura™ (complement factor C5 inhibitor) administered in combination with Lucentis® 0.5 mg in treatment naïve subjects with neovascular age related macular degeneration (NVAMD)
Conditions
- Neovascular Age-related Macular Degeneration
Interventions
Avacincaptad PegolDrug
Avacincaptad Pegol in combination with Lucentis
LucentisDrug
Avacincaptad Pegol in combination with Lucentis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Systemic Adverse EventsTime frame: 6 months
- Ophthalmic Adverse EventsTime frame: 6 months
Locations
28 sites in 3 countries. Site status is shown where the registry gives one.
Retinal Research Institute
Phoenix, Arizona
Retina Centers PC
Tucson, Arizona
Retina Associates SW, PC
Tucson, Arizona
Retina-Vitreous Associates Medical Group
Beverly Hills, California
Retina Consultants of Orange County
Fullerton, California
Retina Consultants of Southern California
Redlands, California
Retinal Consultants Medical Group
Sacramento, California
Orange County Retina Medical Group
Santa Ana, California
Colorado Retina Associates
Golden, Colorado
Florida Eye Clinic
Altamonte Springs, Florida
Florida Eye Associates
Melbourne, Florida
Illinois Eye Center
Peoria, Illinois
Vitreo Retinal Consultants & Surgeons
Wichita, Kansas
Ophthalmic Consultants of Boston
Boston, Massachusetts
VitreoRetinal Surgery
Minneapolis, Minnesota
Retina Consultants of Nevada
Henderson, Nevada
Sierra Eye Associates
Reno, Nevada
Retina Vitreous Surgeons of CNY, PC
Syracuse, New York
Retina Northwest PC
Portland, Oregon
Mid Atlantic Retina
Philadelphia, Pennsylvania
Charleston Neuroscience Institute
Ladson, South Carolina
Retina Research Institute of Texas
Abilene, Texas
Strategic Clinical Research Group
Willow Park, Texas
Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont
Budapest, Hungary
Budapest Retina Associates
Budapest, Hungary
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Szemeszeti Klinika
Szeged, Hungary
Pauls Stradins Clinical University Hospital, Clinic of Ophthalmology
Riga, Latvia
Dr. Solomatin's eye rehabilitation and vision correction centre
Riga, Latvia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.